https://www.natahub.org/ 2024-09-05T12:33:47+01:00 weekly 0.5 https://www.natahub.org/contact-us 2024-09-23T17:55:54+01:00 weekly 0.5 https://www.natahub.org/about-us/about-nata 2024-09-16T15:27:29+01:00 weekly 0.5 https://www.natahub.org/about-us/our-science 2024-09-16T15:29:08+01:00 weekly 0.5 https://www.natahub.org/research-challenges/transnat 2024-09-05T12:31:03+01:00 weekly 0.5 https://www.natahub.org/news-and-events 2024-10-16T12:07:03+01:00 weekly 0.5 https://www.natahub.org/our-team 2024-09-02T12:16:39+01:00 weekly 0.5 https://www.natahub.org/cookie-statement 2024-09-16T15:31:48+01:00 weekly 0.5 https://www.natahub.org/website-privacy-policy 2024-09-03T10:34:58+01:00 weekly 0.5 https://www.natahub.org/accessibility-statement 2024-02-22T10:08:29+00:00 weekly 0.5 https://www.natahub.org/about-us 2024-09-06T10:43:46+01:00 weekly 0.5 https://www.natahub.org/about-us/how-we-work 2024-09-16T15:28:29+01:00 weekly 0.5 https://www.natahub.org/news-and-events/news/new-executive-director-nucleic-acid-therapy-accelerator-nata-appointed 2024-08-22T17:34:58+01:00 weekly 0.5 https://www.natahub.org/news-and-events/news/natas-executive-director-present-keynote-talk-second-annual-oligonucleotide-therapeutics-and-delivery-conference 2024-09-05T11:15:53+01:00 weekly 0.5 https://www.natahub.org/news-and-events/news/nata-partners-epilepsy-research-uk-support-new-cause-focused-research 2024-09-05T11:17:22+01:00 weekly 0.5 https://www.natahub.org/news-and-events/news/nata-awards-pound-6m-consortium-funding-enhance-uks-nucleic-acid-therapeutics-manufacturing-capabilities 2024-08-22T17:35:13+01:00 weekly 0.5 https://www.natahub.org/news-and-events/news/nata-and-epilepsy-research-uk-announce-awardee-co-funded-fellowship-project 2024-09-05T11:10:06+01:00 weekly 0.5 https://www.natahub.org/news-and-events/news/natas-research-scientist-dr-joanna-parkes-received-award-cure-jm-foundation-investigating-potential-nucleic-acid-therapies-jdm 2024-09-05T13:16:26+01:00 weekly 0.5 https://www.natahub.org/research-challenges 2024-07-12T16:23:58+01:00 weekly 0.5 https://www.natahub.org/research-challenges/biomannat 2024-08-23T15:12:24+01:00 weekly 0.5 https://www.natahub.org/publications 2024-11-18T14:38:48+00:00 weekly 0.5 https://www.natahub.org/news-and-events/news/ukri-announcement-new-14-pounds-million-investment-targets-rare-diseases 2024-09-05T13:21:04+01:00 weekly 0.5 https://www.natahub.org/news-and-events/news/precisionlife-and-nata-announce-r-and-d-partnership 2024-10-22T13:12:19+01:00 weekly 0.5 https://www.natahub.org/news-and-events/news/nanovation-therapeutics-uk-and-nata-collaborate-pound-16m-innovate-uk-smart-grant-project-create-one-shot-cure-cancer 2024-12-04T16:13:18+00:00 weekly 0.5 https://www.natahub.org/news-and-events/news/nata-partners-action-t-support-new-fundamental-disease-based-research 2024-09-05T11:15:03+01:00 weekly 0.5 https://www.natahub.org/news-and-events/news/nata-awards-pound-8m-consortium-funding-enhance-uks-nucleic-acid-therapeutics-delivery-platforms 2024-08-22T17:34:27+01:00 weekly 0.5 https://www.natahub.org/news-and-events/events 2024-08-22T17:39:29+01:00 weekly 0.5 https://www.natahub.org/news-and-events/news 2024-08-22T17:33:33+01:00 weekly 0.5 https://www.natahub.org/news-and-events/events/advanced-therapies-integrates-2024 2024-08-23T13:05:33+01:00 weekly 0.5 https://www.natahub.org/research-challenges/researchchallenges 2024-09-16T15:30:26+01:00 weekly 0.5 https://www.natahub.org/publications/characterising-antibodies-targeting-antisense-oligonucleotide-aso-modifications-quantification-intracellular-trafficking-and-viv 2024-09-05T12:29:26+01:00 weekly 0.5 https://www.natahub.org/publications/chemistry-and-biology-oligonucleotide-conjugation 2024-09-05T12:28:59+01:00 weekly 0.5 https://www.natahub.org/publications/interferon-beta-knockdown-using-nucleic-acid-therapeutics-novel-approach-treatment-juvenile-and-adult-dermatomyositis 2024-09-05T12:29:39+01:00 weekly 0.5 https://www.natahub.org/publications/targeting-incrna-smilr-using-sirna-therapeutic-interention-vein-graft-failure 2024-09-05T12:30:33+01:00 weekly 0.5 https://www.natahub.org/publications/pei-supported-delivery-sirna-targeting-smilr-knock-down-therapeutic-intervention-vein-graft-failure 2024-09-05T12:30:15+01:00 weekly 0.5 https://www.natahub.org/publications/investigating-biophysical-properties-and-vivo-activity-75-alpha-biocyclo-dna-backbone-antisense-oligonucleotides 2024-09-05T12:29:53+01:00 weekly 0.5 https://www.natahub.org/news-and-events/news/nata-presents-our-research-3rd-dutch-antisense-therapeutics-symposium 2024-09-05T14:18:55+01:00 weekly 0.5 https://www.natahub.org/news-and-events/news/nata-highlights-nucleic-acid-therapies-rare-disease-resources-and-funding-event 2024-12-05T11:29:56+00:00 weekly 0.5 https://www.natahub.org/news-and-events/news/nata-participates-upnat-inaugural-symposium-ucl-institute-child-health 2024-09-05T14:07:54+01:00 weekly 0.5 https://www.natahub.org/publications/thiol-specific-linkers-synthesis-oligonucleotide-conjugates-metal-free-thiol-ene-click-reaction 2024-09-16T13:16:10+01:00 weekly 0.5 https://www.natahub.org/publications/thiol-specific-linkers-synthesis-oligonucleotide-conjugates-metal-free-thiol-ene-click-reaction-1 2024-09-16T13:14:57+01:00 weekly 0.5 https://www.natahub.org/publications/thiol-specific-linkers-synthesis-oligonucleotide-conjugates-metal-free-thiol-ene-click-reaction-2 2024-09-23T09:45:18+01:00 weekly 0.5 https://www.natahub.org/publications/peptide-oligonucleotide-conjugation-chemistry-and-therapeutic-applications 2024-09-30T15:08:44+01:00 weekly 0.5 https://www.natahub.org/news-and-events/news/pete-oliver-represented-nata-recent-cambridge-new-therapeutics-forum 2024-11-18T15:50:06+00:00 weekly 0.5 https://www.natahub.org/publications/towards-utilizing-vh-single-domain-oligonucleotide-conjugates-carriers-oligonucleotide-therapeutics-tissue-and-cellular-targets 2024-10-07T13:38:26+01:00 weekly 0.5 https://www.natahub.org/publications/characterising-antibodies-targeting-antisense-oligonucleotide-aso-modifications-quantification-vitro-intracellular-trafficking-a 2024-11-20T21:16:29+00:00 weekly 0.5 https://www.natahub.org/news-and-events/news/pcd-research-and-nata-co-fund-grant-advance-therapy-primary-ciliary-dyskinesia 2024-10-29T10:02:03+00:00 weekly 0.5 https://www.natahub.org/news-and-events/news/nata-presents-2024-annual-meeting-oligonucleotide-therapeutics-society 2024-11-20T21:16:08+00:00 weekly 0.5 https://www.natahub.org/news-and-events/news/ariz-precision-medicine-and-nata-announce-collaboration 2024-12-02T14:03:17+00:00 weekly 0.5